Search | Page 6 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Tea consumption reduces the risk of de novo myelodysplastic syndromes

    ... in the refractory anemia with excessive blasts subtype, in cytogenetic 'good' and 'intermediated/poor' prognosis ...

    Research Article last updated 01/20/2015 - 12:56pm.

  2. Prolonged survival with improved tolerability in higher-risk myelodysplastic syndromes: azacitidine compared with low dose ara-C.

    ... subtypes refractory anaemia with excess blasts (RAEB) and RAEB in transformation. When analyzed per patient year ...

    Research Article last updated 10/11/2011 - 5:58pm.

  3. The impact of hypomethylating agents on the cost of care and survival of elderly patients with myelodysplastic syndromes

    ... anemia or refractory anemia with excess blasts ). The magnitude of the cost of care underscores a need for ...

    Research Article last updated 10/01/2012 - 9:41am.

  4. 5-Azacytidine in myelodysplastic syndromes: a clinical practice guideline.

    ... and high risk scores including WHO-defined AML (20-30% blasts ) who cannot proceed immediately to allogeneic stem cell ...

    Research Article last updated 10/11/2011 - 5:58pm.

  5. Personalized medicine for MDS

    ... who does not require transfusions, has no increase in blasts , nor any poor-risk cytogenetic abnormalities. These patients, ...

    Research Review last updated 05/02/2016 - 9:44am.

  6. MDS - Treatment (OLD)

    ... abnormal bone marrow cells  Reduce the number of blasts (young white blood cells) in your bone marrow that have an abnormal ... between 0 and 1.0 Do not usually have an excess of blasts in the bone marrow This type of care includes: ...

    Topic section last updated 03/10/2016 - 11:01pm.

  7. Myeloablative Unrelated Donor Cord Blood Transplantation With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cells for Patients With High Risk Hematological Malignancies

    ... or relapse/ refractory less than or equal to 10% blasts in bone marrow , or aplasia post-therapy. This includes ... in CR, or relapse with less than or equal 10% bone marrow blasts. CML with tyrosine kinase inhibitor failure in chronic or ...

    Clinical Trial last updated 04/29/2016 - 1:33pm.

  8. Understanding Prognosis in MDS

    ... help determine prognosis—the percentage of bone marrow blasts (immature white blood cells), the number of cytopenias (low blood ... to help determine prognosis—the percentage of bone marrow blasts (immature white blood cells), the number of cytopenias (low blood ...

    Interview last updated 05/02/2012 - 4:36pm.

  9. Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders

    ... or Mylotarg) MDS: Patients must have < 10% marrow blasts ; fewer than 10% marrow blasts must be documented by marrow examination within 3 weeks of initiation of ...

    Clinical Trial last updated 04/28/2016 - 2:45pm.

  10. MDS: Diagnosis

    ... bone marrow which are immature white blood cells called blasts . In people with AML, blasts make copies of themselves quickly. This slows the production of red ...

    Page last updated 01/20/2015 - 4:42pm.